Over the past two decades, the growth of most Chinese medical device companies has been driven by import substitution; as the level of domestic production increases, expanding overseas has become an inevitable choice for many enterprises. The overseas market space for medical devices is several times larger than that of China, serving as a source for multi-fold growth opportunities for medical device companies. We are witnessing rapid high growth in the international business of more and more companies, with their overseas revenue share quickly rising or even surpassing domestic figures. Companies whose internationalization capabilities have gained recognition are seeing valuation increases, with future valuations expected to align with those of leading U.S. medical device stocks.
Some Chinese medical device companies are poised to emerge as global leaders or dominant players in niche segments. Consequently, assessing the internationalization capabilities and potential of each segment and enterprise will become the most critical decision-making factor for investment in the medical device industry.
Against this backdrop, at 15:00 on Wednesday, February 11, VCBeat and Wei Jieyao jointly hosted the “China Innovative Medical Asset Lounge” Insight RelativityIssue 4, featuringZhu Qizhang, Medical Device Industry Analyst at China Securities Co., Ltd.Centered onMedical Device Internationalization: Vast Opportunities in Overseas Markets, Domestic Leaders Poised for TakeoffTopic Sharing,

Guest: Zhu Qizhang
CSC Financial Securities Medical Device Industry Analyst

Holds a B.S. in Biology from Nanjing University and an M.Fin. from ParisTech. With six years of experience in sell-side industry research, focuses on analyzing development trends and investment opportunities in sectors such as medical equipment, the upstream supply chain of medical devices, high-value consumables, and precision oncology diagnostics. The team has published in-depth reports including [Equipment Segment of the Medical Device Industry Chain Series: Broad Perspective with Focused Selection, Poised for Growth], [Medical Device Industry Upgrade Series Report I: The Inflection Point Has Arrived—Innovation, M&A, and Global Expansion Forge Worldwide Leaders], and [Medical Device Industry Upgrade In-Depth Series Report II: Significant Opportunities in Overseas Markets, Chinese Leaders Poised for Expansion].
Medical Device Internationalization: Vast Opportunities in Overseas Markets, Domestic Leaders Poised for Takeoff
●How to evaluate the internationalization capabilities and potential of companies in different sectors?
● Analyze the experiences of enterprises with excellent internationalization capabilities
● Recommendations for Medical Device Investment and Global Expansion Strategies
China's Innovative Medical Assets Reception Hall
“China’s Innovative Healthcare Asset Lounge” is an online live-streaming program launched by VCBeat, positioned around the core mission of “connecting China’s innovative healthcare assets with global buyers.” It focuses on high-quality asset transactions in fields such as innovative drugs, high-end medical devices, and digital health, aiming to build a professional platform for “presentation, communication, and matchmaking” tailored to strategic, financial, and industrial buyers. With the goal of “unlocking the value of China’s innovative assets and facilitating efficient transactions,” the program helps buyer groups capture opportunities in premium assets through precise supply-demand matching, analysis of transaction logic, and sharing of practical experience. Meanwhile, it promotes the conversion and retention of local innovative assets, contributing to the ecosystem development of the Global Life and Health Innovative Asset Buyers Alliance.

Scan the QR code to reserve your spot for the live stream.
Call for Nominations Launched for the 2026 Future Healthcare Top 100!
The 2026 Top 100 Future Healthcare Companies selection is anchored in the core direction of “Innovation, Transaction, and Empowerment in China’s Healthcare Industry,” achieving a comprehensive upgrade of its evaluation system. This edition features two core components: the 2026 Top 100 Future Healthcare Companies List and the 2026 Top 100 Future Healthcare Companies Awards.

Scan the QR code to learn more about application details.